Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

15%

4 trials in Phase 3/4

Results Transparency

17%

2 of 12 completed with results

Key Signals

2 with results86% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (7)
Early P 1 (1)
P 1 (3)
P 2 (3)
P 3 (4)

Trial Status

Completed12
Unknown4
Recruiting4
Not Yet Recruiting2
Terminated2
Withdrawn1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT06327113Phase 2RecruitingPrimary

Antibiotic Tumescent For Chronic Wounds

NCT04914247UnknownPrimary

Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger's Disease

NCT06328010Enrolling By Invitation

Clinical Registry Collecting Real World Evidence on Wound Care Treatments

NCT03632031Not ApplicableCompletedPrimary

Treatment of Wounds Using Oasis® ECM

NCT06707090Phase 3Recruiting

Tissue Repair Gel in Venous Leg Ulcers (US)

NCT05739149Not ApplicableRecruiting

A Study to Evaluate Microvessel Ultrasound Imaging of Wound Healing in Patients With Chronic Ulcers

NCT06109844Completed

FORCEREPAIR - A Wound Exudate Investigation

NCT06707103Phase 3Recruiting

Tissue Repair Gel in Venous Leg Ulcers in AU/US

NCT04450693Phase 3Completed

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)

NCT06758427Not Yet Recruiting

Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation

NCT05766982Not ApplicableWithdrawnPrimary

Kerecis Fish Skin Grafts With and Without Platelet Rich Plasma (PRP)

NCT05251480Not ApplicableNot Yet Recruiting

Examining the Effectiveness of DermGEN™ in the Treatment of Diabetic Foot Ulcers in First Nations People

NCT05921292Early Phase 1CompletedPrimary

Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

NCT04176120Phase 3Completed

Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)

NCT06442865CompletedPrimary

AMNIODERM+ Medical Device Clinical Study

NCT06028386Not ApplicableUnknownPrimary

Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers

NCT05154838Completed

Development of Volatile Organic Compounds (VOC) Analysis as a Potential Diagnostic for Infected and Non-Healing Wounds

NCT04240574Not ApplicableTerminated

Debritom - Micro Water Jet Technology and Wound Healing

NCT03863054Completed

An Observational Clinical Trial Examining the Effect of Topical Oxygen Therapy (NATROX™) on the Rates of Healing of Chronic Diabetic Foot Ulcers

NCT03230175Phase 2CompletedPrimary

Phase 2 Pilot Trial of Subjects With Complex Non-healing Diabetic Foot Ulcers Treated With Standard Care Plus Cryopreserved Umbilical Cord Allograft (TTAX01)

Scroll to load more

Research Network

Activity Timeline